TFDP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.091800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.186000E-01
Normal-vs-Stage2
6.149400E-01
Normal-vs-Stage3
5.629400E-01
Normal-vs-Stage4
5.101800E-01
Stage1-vs-Stage2
6.085400E-01
Stage1-vs-Stage3
1.460620E-01
Stage1-vs-Stage4
7.656400E-01
Stage2-vs-Stage3
1.483820E-01
Stage2-vs-Stage4
8.988800E-01
Stage3-vs-Stage4
2.911000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.228000E-01
Normal-vs-AfricanAmerican
4.668200E-01
Normal-vs-Asian
7.304000E-01
Caucasian-vs-AfricanAmerican
6.597800E-01
Caucasian-vs-Asian
6.857800E-01
AfricanAmerican-vs-Asian
4.746400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.627800E-01
Normal-vs-Female
5.423200E-01
Male-vs-Female
5.663800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.232200E-01
Normal-vs-Age(41-60Yrs)
4.093000E-01
Normal-vs-Age(61-80Yrs)
7.272600E-01
Normal-vs-Age(81-100Yrs)
4.613800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.767400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.960800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.879400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.069400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.796000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.112200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.134800E-01
Normal-vs-Daily Drinker
9.509000E-01
Normal-vs-Weekly Drinker
6.344800E-01
Normal-vs-Occasional Drinker
1.595210E-01
Normal-vs-Social Drinker
5.167000E-01
Non Drinker-vs-Daily Drinker
7.195800E-01
Non Drinker-vs-Weekly Drinker
6.526400E-01
Non Drinker-vs-Occasional Drinker
2.850300E-02
Non Drinker-vs-Social Drinker
4.771400E-01
Daily Drinker-vs-Weekly Drinker
4.131600E-01
Daily Drinker-vs-Occasional Drinker
1.063850E-02
Daily Drinker-vs-Social Drinker
2.727800E-01
Weekly Drinker-vs-Occasional Drinker
7.107800E-02
Weekly Drinker-vs-Social Drinker
7.752400E-01
Occasional Drinker-vs-Social Drinker
1.124180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.332000E-01
Normal-vs-Grade 2
5.968600E-01
Normal-vs-Grade 3
1.088390E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.732200E-01
Grade 1-vs-Grade 3
2.198800E-01
Grade 1-vs-Grade 4
3.332000E-01
Grade 2-vs-Grade 3
7.903000E-01
Grade 2-vs-Grade 4
5.968600E-01
Grade 3-vs-Grade 4
1.088390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.723600E-01
Normal-vs-NonDiabetic
5.504400E-01
Diabetic-vs-NonDiabetic
5.958200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.098000E-01
Normal-vs-NoPancreatitis
6.721600E-01
Pancreatitis-vs-NoPancreatitis
9.798000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.669000E-01
Normal-vs-N1
6.170800E-01
N0-vs-N1
9.003800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.803600E-01
Normal-vs-TP53-NonMutant
7.711200E-01
TP53-Mutant-vs-TP53-NonMutant
8.242900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
